Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (148 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Oct 2024 – 20 Aug 2026, limited by Mirae Asset Gold ETF Fund of Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset Gold ETF Fund of Fund | Gold |
|---|---|---|
| 28 Oct 2024 | ₹100.00 | ₹100.00 |
| 22 Dec 2024 | ₹96.70 | ₹96.26 |
| 15 Feb 2025 | ₹109.93 | ₹109.79 |
| 11 Apr 2025 | ₹117.97 | ₹118.43 |
| 05 Jun 2025 | ₹123.87 | ₹124.25 |
| 30 Jul 2025 | ₹125.27 | ₹125.25 |
| 24 Sep 2025 | ₹143.45 | ₹143.87 |
| 18 Nov 2025 | ₹152.82 | ₹153.41 |
| 12 Jan 2026 | ₹175.84 | ₹177.50 |
| 08 Mar 2026 | ₹197.03 | ₹198.88 |
| 02 May 2026 | ₹185.62 | ₹187.64 |
| 26 Jun 2026 | ₹173.03 | ₹174.76 |
| 20 Aug 2026 | ₹193.64 | ₹195.93 |
| Metric | Mirae Asset · Regular NAV ₹19.44 High risk ★★★★☆ 1Y | Category median FoF Domestic · 148 funds |
|---|---|---|
| +55.71% | +7.03% | |
| — | +13.88% | |
| — | +11.19% | |
| — | +11.61% | |
| +44.08% | +10.54% | |
| +42.81% | — | |
| — | +12.35% | |
| — | +10.37% | |
| — | +8.94% | |
| Risk | ||
| 24.61% | 15.84% | |
| 2.00 | 0.70 | |
| 2.83 | 0.97 | |
| -23.85% | -19.67% | |
| Gold | — | |
| — | +1.35% | |
| — | 0.94 | |
| — | 97.2% | |
| — | 93.6% | |
| 0.69% | 0.58% | |
| ₹523.19Cr | ₹226.32Cr | |
| 0.05% | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| — | 10% | |
| Ritesh Patel · 1.8y | — | |
| 28 Oct 2024 | — | |
| — | — | |
| — | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.